5,0
17 gen 2024
Dipendente anonimo
Dipendente attuale, più di 3 anni
Stoccolma,
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
A leader in its field - developing medicines to treat Alzheimer's disease, Parkinson's disease and ALS. Great science, great people, great culture!
Svantaggi
Only present in the Nordic countries currently, but growing quickly.